Genetic Analysis of Italian Patients with Congenital Hyperinsulinism of InfancySogno Valin P. · Proverbio M.C. · Diceglie C. · Gessi A. · di Candia S. · Mariani B. · Zamproni I. · Mangano E. · Asselta R. · Battaglia C. · Caruso-Nicoletti M. · Mora S. · Salvatoni A.
aDepartment of Pediatrics, San Raffaele Scientific Institute, Milan, bDipartimento di Fisiopatologia e dei Trapianti (DePT), Università degli Studi di Milano, Milan, cLaboratory of Pediatric Endocrinology, Division of Metabolic and Cardiovascular Sciences, San Raffaele Scientific Institute, Milan, dScuola di Dottorato di Medicina Molecolare, Università degli Studi di Milano, Milan, eInstitute of Biomedical Technology (ITB), CNR, Segrate and fDipartimento di Biotecnologie Mediche e Medicina Traslazionale (BIOMETRA), Università degli Studi di Milano, Milan, gDepartment of Clinical and Experimental Medicine, Pediatric Unit, Insubria University, Varese, and hDipartimento di Scienze Mediche e Pediatriche, Università di Catania, Catania, Italy
Background/Aims: Congenital hyperinsulinism of infancy is a rare disease that needs prompt treatment to avoid brain damage. There are currently no data regarding the clinical and molecular features of Italian patients. Methods: Thirty-three patients with HI and their parents were included. Consanguinity was reported in six patients. Half of patients were macrosomic at birth. None had raised 3-hydroxybutyrylcarnitine or hyperammonemia. Molecular analysis of ABCC8 and KCNJ11 genes was performed in all patients, and subjects with no mutation underwent analysis of HNF4A and GCK. GLUD1 and HADH genes were analyzed in a patient with leucine sensitivity. Results: Mutations in the ABCC8 and KCNJ11 genes were found in 45% of the patients (6 novel). No mutations in HNF4A, GLUD1 and GCK genes were found. Recessive mode of inheritance was found in 21% of patients. A single heterozygous mutation was identified in 24% of probands. 72% of the patients were responsive to medical treatment, and 44% of the 17 patients with no identified mutation achieved spontaneous remission. Nine children, unresponsive to medical therapy, underwent pancreatectomy. Conclusion: This is the first report on hyperinsulinism of infancy in Italy, confirming the complexity of the clinical forms and the heterogeneity of the genetic causes of the disease.
Stefano Mora, MD
Laboratory of Pediatric Endocrinology
San Raffaele Scientific Institute, Via Olgettina 60
IT-20132 Milano (Italy)
P. Sogno Valin and M.C. Proverbio contributed equally to this work.
Received: November 30, 2012
Accepted: March 13, 2013
Published online: May 1, 2013
Number of Print Pages : 7
Number of Figures : 1, Number of Tables : 1, Number of References : 26
Hormone Research in Paediatrics (From Developmental Endocrinology to Clinical Research)
Vol. 79, No. 4, Year 2013 (Cover Date: May 2013)
Journal Editor: Czernichow P. (Paris)
ISSN: 1663-2818 (Print), eISSN: 1663-2826 (Online)
For additional information: http://www.karger.com/HRP